期刊文献+

急性缺血性脑卒中血管再通方法的比较性研究 被引量:8

Recanalization of Acute Ischemic Stroke Methods Comparative Research
原文传递
导出
摘要 急性缺血性脑卒中(AIS)的预后与急性期的血管再通密切相关。评价血管再通效率的标准有3条,即血管再通率、临床转归率和不良反应。AIS血管再通的方法有静脉溶栓、动脉溶栓、动静脉溶栓、机械再通术,机械再通术又分为支架再通术和机械碎栓/取栓术再通术。从血管再通效率的评价标准而言,机械再通术虽血管再通率高,但不良反应较多,且临床转归率并未提高多少;而静脉溶栓虽血管再通率不及机械再通术,但临床转归率也不低,不良反应明显减少,是首选之血管再通治疗方法。 Acute ischemic stroke (AIS) prognosis is closely related to the acute phase of recanalization. There are three evaluation criteria of efifciency of recanalization, namely blood vessels, clinical outcome rate and the rate of pay. AIS recanalization method with intravenous thrombolysis, artery thrombolysis, arteriovenous thrombolysis, mechanical recanalization. Mechanical recanalization is divided into stent recanalization and mechanical broken bolt/take bolt recanalization. Exactly what kind of method, from the evaluation standard of recanalization efficiency, is better? Is the preferred treatment? The results of the comparative study showed that mechanical recanalization had high recanalization rate but with much untoward effect and low clinical outcome rate. Intravenous thrombolysis is the ifrst choice for recanalization treatment because of high clinical outcome rate with decreased signiifcantly fee, though a less mechanical recanalization rate of blood vessels.
作者 涂雪松
出处 《中国临床神经科学》 2015年第2期205-211,共7页 Chinese Journal of Clinical Neurosciences
关键词 急性缺血性脑卒中 血管再通 溶栓 支架置入术 机械再通术 颅内动脉粥样硬化性狭窄 acute ischemic stroke recanalization thrombolysis carotid stenting mechanical recanalization intracranial atherosclerotic stenosis
  • 相关文献

参考文献2

二级参考文献99

  • 1Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282.
  • 2Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005.
  • 3Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442.
  • 4Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213.
  • 5Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7.
  • 6Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312.
  • 7Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617.
  • 8Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439.
  • 9Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032.
  • 10Kwiatkowski TG, Libman RB, Fmnkel M, et al. Effects of tissue plasrrfinogen activator for acute ischemic stroke at one year. National Institute of Neurological Disordeis and Stroke Recombinxaat Tissue Plasmiogen Activator Stroke Study Group. N Engl J Med, 1999, 340: 1781-1787.

共引文献990

同被引文献94

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1847
  • 2Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet, 2013, 381(9882): 1987-2015.
  • 3Miao Z, Jiang L, Wu H, et al. Randomized controlled trial of symptomatic middle cerebral artery stenosis: endovascular versus medical therapy in a Chinese population[J]. Stroke, 2012, 43(12): 3284-3290.
  • 4Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial[J]. Stroke, 2005, 36(7): 1432-1438.
  • 5Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I[J]. AJN Am J Neuroradiol, 2006, 27(6): 1177-1182.
  • 6Saver JL1, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial[J]. Lancet, 2012, 380(9849): 1241-1249.
  • 7Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease[J]. Stroke, 2009, 40(8): 2761-2768.
  • 8Hussain SI, Zaidat OO, Fitzsimmons BF. The Penumbra system for mechanical thrombectomy in endovascular acute isehemic stroke therapy[J]. Neurology, 2012, 79(13 Suppl 1): S135-S141.
  • 9San Roml L, Obach V, Blasco J, et al. Single-center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke [J]. Stroke, 2012, 43 (6): 1657-1659. .
  • 10Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial[J]. Lancet, 2012, 380(9849): 1231-1240.

引证文献8

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部